Spine Motion Guide

Laminectomy

Laminectomy Success Rates: What Does the Research Say?

Laminectomy research does not support one success percentage. In a major stenosis trial, the assigned-group analysis found a benefit for surgery on bodily pain at two years, and not on physical function or a disability score. Another operation and a satisfaction rating are separate questions. A rating from a chronic back pain fusion trial is not a laminectomy result.

By Spine Motion Guide

Published

12 min read

How we source articles

Illustration of an adult with short hair walking across a mat in a therapy room with wall bars and an exercise ball

Search for a laminectomy result and you will be offered one percentage, as if pain, walking, a second operation, and the feeling of being better were the same event. They are not. A single success rate is the wrong summary, because those outcomes were measured separately, in different studies, and they did not move together even inside one trial.

This article keeps the rows apart. It does not publish a success percentage, because no honest percentage survives the split.

What the operation removes is described in What Is a Laminectomy? Whether fusion should be added is a different argument, in Is a Laminectomy Alone Enough for Spinal Stenosis? The pages below are about how to read a result once “did it work” has been allowed to mean four things.

Why one percentage is the wrong summary

MedlinePlus describes laminectomy for spinal stenosis in words, not in a rate. It often provides full or some relief. Partial or no relief is listed among the risks.

Future spine problems remain possible. “Full or some” is already two outcomes. A page that turned that sentence into one success rate would be throwing away the only precision the sentence had.

Patients usually care about leg pain first: pain, numbness, or heaviness that limits standing and walking. Function is the next question, and it is not the same question. You can hurt less and still walk poorly.

You can walk farther and still be unhappy with the result. Reoperation, meaning another operation later, is a third question. Satisfaction, meaning you rate yourself better, is a fourth. Mixing them produces a number that cannot be checked against any one of them.

Outcomes

Measured separately, because they are separate

A single success rate is the wrong summary. Pain, function, another operation, and satisfaction do not become one percentage just because they follow the same operation.

Leg pain

The symptom most people mean. In one stenosis trial, the assigned-group analysis found a benefit on bodily pain at two years. That is a pain result, not the whole trial.

Function

Walking and daily limits. In that same assigned-group analysis, surgery did not show a significant benefit on physical function or the Oswestry Disability Index.

Another operation

Reoperation is its own count. The pain result above is not a reoperation percentage, and this article does not invent one from it.

Satisfaction

A self-rating of being better. The figure people quote for this comes from a chronic back-pain fusion trial, not from a laminectomy trial.

If a percentage cannot be filed under one of these four, it is not a result you can use.

The rest of this article fills those four boxes with the studies that actually speak to them. Where a study is silent, the box stays silent. Silence is more accurate than a borrowed percent.

Pain moved. Function, in the assigned groups, did not

The clearest head-to-head evidence for surgery versus non-surgical care in lumbar stenosis, without a slip, is the SPORT stenosis trial. It enrolled surgical candidates who had stenosis and did not have spondylolisthesis. The primary outcomes were a bodily-pain score, a physical-function score, and the Oswestry Disability Index, which asks how back problems limit ordinary activities. Follow-up for the finding below is two years.

In the intention-to-treat analysis, people stayed in the group they were assigned to, even if they later crossed to the other treatment. On that analysis, surgery had a significant benefit on bodily pain at two years. It did not have a significant benefit on physical function.

It did not have a significant benefit on the Oswestry Disability Index. Pain and function came apart. That split is the reason a single success rate is the wrong summary of this paper.

Quoting only the pain benefit makes surgery look simpler than the assigned-group result. Quoting only the non-significant function result hides a real pain difference.

Bodily pain is not a perfect synonym for leg pain. The score asks about pain in the body. Leg pain, numbness, and walking tolerance are the stenosis story patients tell, and they can move differently from a general pain score and from a disability form.

Leg-pain relief and walking are different outcomes even before statistics. If your goal is “I want the burning in my calves to ease when I walk to the store,” say that. Do not let it be translated into “the operation works” and then into a percentage the trial did not publish as one number.

Crossover was heavy. Many people assigned to non-surgical care later had surgery, and some assigned to surgery did not have it. That is why the assigned-group result is hard to read as “surgery versus staying with care,” and why researchers also reported a second analysis. Heavy crossover is a feature of the trial, not a detail to skip on the way to a cleaner percent.

The second analysis is not a replacement percent

The as-treated analysis combined the randomized cohort with an observational cohort, looked at the treatment people actually received, and adjusted for differences between groups. On that analysis, surgery was better on all of the primary outcomes. Bodily pain, physical function, and the disability score all favored surgery.

Both analyses are in the same paper. The assigned-group result says: if you keep people where randomization put them, the two-year benefit is on bodily pain, not on physical function or the disability index. The as-treated result says: looking at what people actually underwent, and adjusting, surgery looks better across those primary outcomes.

Using only the second sentence to declare a success rate is the wrong summary, because it deletes the first sentence and the crossover that made the two sentences necessary. Using only the first sentence deletes a result the authors also reported.

Neither analysis is a reoperation percentage. The intention-to-treat pain result is not a count of people who had another operation, and this article will not invent one. Reoperation has to come from studies that counted it.

SPORT’s contribution here is the split between pain and function, plus the warning that crossover changes what a comparison means. That is enough. It is already more useful than one number.

Outcomes that stay in their own rows
Outcome Where it was measured What happened Wrong summary
Bodily pain SPORT, stenosis without a slip, two years, assigned groups Surgery had a significant benefit Treat that benefit as the whole result
Function Same trial and analysis: physical function and the Oswestry Disability Index No significant benefit Pretend pain and function were the same outcome
All primary outcomes, treatment received SPORT as-treated analysis, randomized plus observational, adjusted Surgery better on all primary outcomes Erase the assigned-group split and the heavy crossover
Reoperation Not taken from the SPORT pain result. Counted in two different fusion-versus-decompression trials 22 percent versus 21 percent over a mean of 6.5 years; 14 percent versus 34 percent through four years Call either pair a laminectomy result for every patient
Satisfaction Fritzell trial, chronic low back pain, fusion, ages 25 to 65, two years 63 percent versus 29 percent better or much better Call 63 percent a laminectomy success rate

Reoperation is its own outcome

Another operation is not the opposite of pain relief. Someone can feel better and still have a later procedure for a new problem, a complication, or a level that was not the original target. Someone can have no further surgery and still be limited. Counting reoperation answers “did they go back to the operating room,” which is worth knowing and is not a pain score.

The Swedish Spinal Stenosis Study randomized 247 people ages 50 to 80 with stenosis at one or two levels, 135 of them with a degenerative slip, to decompression alone or decompression plus fusion. Additional spine surgery over a mean of 6.5 years was 22 percent after fusion and 21 percent after decompression alone. That near-match is not a laminectomy success rate.

It is a later-surgery count in a trial about adding fusion. It also is not the SPORT intention-to-treat result rewritten as a percentage. SPORT did not supply this number.

The SLIP trial randomized 66 people with stable grade I degenerative spondylolisthesis and stenosis. Reoperation through four years was 14 percent after fusion and 34 percent after decompression alone. Again, this is another operation, in a narrower group, over a stated follow-up.

It disagrees with the Swedish later-surgery result in an important way: here fusion was followed by fewer reoperations. The disagreement is why the two pairs must stay labeled. Averaging 22, 21, 14, and 34 into one laminectomy figure would be the wrong summary in arithmetic form.

How to read those fusion trials as a choice, rather than as a score, is the work of the laminectomy-alone article linked above. How fusion results themselves get pulled apart into bone, pain, function, reoperation, and satisfaction is covered in how those fusion outcomes are separated. This page borrows the reoperation rows only to show that they are rows, not a rate for decompression in general.

Satisfaction came from a different kind of trial

Satisfaction is the outcome that most often gets promoted into a percentage, because it sounds like “it worked.” The figure to be careful with is from the Swedish Lumbar Spine Study Group trial of fusion for chronic low back pain. It enrolled 294 people, ages 25 to 65.

At two years, 63 percent of the fusion group and 29 percent of the non-surgical group rated themselves better or much better. The non-surgical care was the physical therapy approaches used in that trial. Care offered today may not match it. The operation was fusion for chronic back pain, not a laminectomy for stenosis.

Calling 63 percent a laminectomy success rate would be the wrong summary. The people were younger than a typical stenosis practice. The complaint was chronic low back pain, not the walking-and-leg pattern stenosis surgery is usually aimed at.

The comparison operation was fusion, which stops motion, not decompression alone. The outcome was a global self-rating. A self-rating can be true and still not be leg pain, not be the disability score, and not be a count of reoperation.

Sixty-three versus twenty-nine is a contrast inside that trial. It is not a number you can carry into a laminectomy consent and still be talking about the same thing.

The clinical evidence page is where results stay tied to the people who were studied, including device evidence that has its own endpoints. A satisfaction rating from 2001 does not become laminectomy evidence by being the only percentage in the conversation. If a consult offers 63 percent, ask whether the study was fusion for chronic back pain.

If it was, you have identified the row. You have not identified your result.

How to ask without collapsing the rows

Before you consent, name the outcome in a sentence you could check later. “I want to walk farther than one block” is function. “I want the leg pain to drop” is pain.

“I want to avoid another operation” is reoperation, and you should hear that no SPORT percentage for that wish is on offer here. “I want to feel better overall” is satisfaction, and the 63 percent figure is the wrong study for a laminectomy. Writing the sentence first makes it harder for a mixed percentage to answer a question you did not ask.

Then name the comparison. Surgery versus non-surgical care, in stenosis without a slip, is SPORT, with crossover and with pain and function splitting in the assigned-group analysis. Decompression versus decompression plus fusion is a different pair of trials, and they did not agree on later surgery.

Fusion versus the non-surgical care of 2001, for chronic low back pain, is the satisfaction contrast. Three comparisons, four outcomes. A success rate that ignores the grid is the wrong summary even when every cell inside the grid is real.

After surgery, keep the sentence you wrote. Partial relief can be a success on leg pain and a disappointment on walking distance, and MedlinePlus already allows both full and partial relief without calling either one a rate. Future problems can still happen.

If the pain is better and a later scan looks worn somewhere else, that is a new question, not a revision of the original percentage. If the pain is not better, say so. Do not let a global rating, or someone else’s trial, talk you out of the outcome you are actually living.

There is no laminectomy success rate in this article because publishing one would require pretending the rows are the same row. They are not. Pain, function, reoperation, and satisfaction each have a place to stand, a study that speaks to that place, and a misuse that has to be refused.

The refusal is the result. The percentage, if someone still wants to say one, does not survive it.

Frequently asked questions

What number should I ask for if I want to know whether a laminectomy works?

Ask which outcome, in which people, compared with what, and at what time. A single success rate is the wrong summary, because pain, function, reoperation, and satisfaction were not measured as one thing. In the stenosis trial that kept people in their assigned groups, surgery showed a benefit on bodily pain at two years and not on physical function or the disability questionnaire. That split is the finding. A percentage that hides the split is less informative than the split. Bring the symptom you care about, usually leg pain or walking, and ask for the result that matches it.

Does the SPORT trial mean surgery works for every tight canal?

No. SPORT enrolled surgical candidates with lumbar stenosis and no spondylolisthesis. Many people crossed between surgery and non-surgical care, so the two analyses answer different questions. Kept in assigned groups, surgery had a significant benefit on bodily pain at two years, not on physical function or the Oswestry Disability Index. The analysis of treatment actually received, combining randomized and observational patients and adjusting, found surgery better on all primary outcomes. Both statements are in the paper. Neither is a personal probability, and neither applies automatically to someone who is walking well or to someone who has a slip.

Is a later operation a failed laminectomy?

It is a separate outcome. This article does not take a reoperation percentage from the SPORT pain result, because that result was not a count of second operations. Other trials did count later surgery, and they were comparing decompression with decompression plus fusion, not surgery with non-surgical care. In one, additional surgery over a mean of 6.5 years was 22 percent after fusion and 21 percent after decompression alone. In a smaller grade I slip trial, reoperation through four years was 14 percent versus 34 percent. Those figures are not a laminectomy score, and they are not interchangeable.

I read that 63 percent of people were better. Is that the laminectomy figure?

No. In a chronic low-back-pain trial, 294 people ages 25 to 65 were assigned to fusion or to non-surgical care built from the physical therapy of that period. At two years, 63 percent of the fusion group and 29 percent of the comparison group rated themselves better or much better. That is a satisfaction contrast from a fusion trial, not a laminectomy trial. Calling 63 percent a laminectomy success rate would be the wrong summary. Satisfaction is not leg pain, not walking, and not a count of another operation. Modern non-surgical care may also differ from what that trial used.

If relief is only partial, did the operation fail?

MedlinePlus describes laminectomy for stenosis as often providing full or some relief, and it lists partial or no relief among the risks. Some relief and full relief are both inside that sentence. Future spine problems can still occur, including at other levels, so a good year is not a lifetime warranty. Partial relief can be a meaningful change in leg pain and still leave limits in walking or daily tasks. Judge the result against the outcome you named before surgery. A single percentage cannot do that job, which is why this article refuses to publish one.

Key takeaways

  • A single success rate is the wrong summary. Pain, function, reoperation, and satisfaction answer different questions.
  • In SPORT, assigned-group results at two years showed a benefit for surgery on bodily pain, not on physical function or the Oswestry Disability Index. Crossover was heavy.
  • The as-treated analysis found surgery better on all primary outcomes. That is a different analysis, not a correction that erases the first one.
  • A 63 percent versus 29 percent satisfaction rating comes from a chronic low-back-pain fusion trial, not from a laminectomy trial.

References

  1. Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical versus nonsurgical therapy for lumbar spinal stenosis. The New England Journal of Medicine. 2008;358(8):794-810. 2008.
  2. Fritzell P, Hägg O, Wessberg P, Nordwall A. Lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine. 2001;26(23):2521-2532. 2001.
  3. Försth P, Ólafsson G, Carlsson T, et al. A Randomized, Controlled Trial of Fusion Surgery for Lumbar Spinal Stenosis. The New England Journal of Medicine. 2016;374(15):1413-1423. 2016.
  4. Ghogawala Z, Dziura J, Butler WE, et al. Laminectomy plus Fusion versus Laminectomy Alone for Lumbar Spondylolisthesis. The New England Journal of Medicine. 2016;374(15):1424-1434. 2016.
  5. Laminectomy. MedlinePlus Medical Encyclopedia, U.S. National Library of Medicine. 2024.

Review the clinical evidence

See what the FDA reviewed for the TOPS System, which patients were studied, how success was defined, and where the evidence has limits.

Review the clinical evidence